A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
Journal
Signal transduction and targeted therapy
ISSN: 2059-3635
Titre abrégé: Signal Transduct Target Ther
Pays: England
ID NLM: 101676423
Informations de publication
Date de publication:
20 Apr 2024
20 Apr 2024
Historique:
received:
04
07
2023
accepted:
07
03
2024
revised:
30
01
2024
medline:
21
4
2024
pubmed:
21
4
2024
entrez:
20
4
2024
Statut:
epublish
Résumé
Strategies to improve T cell therapy efficacy in solid tumors such as hepatocellular carcinoma (HCC) are urgently needed. The common cytokine receptor γ chain (γ
Identifiants
pubmed: 38643203
doi: 10.1038/s41392-024-01792-6
pii: 10.1038/s41392-024-01792-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
101Informations de copyright
© 2024. The Author(s).
Références
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
pubmed: 33538338
doi: 10.3322/caac.21660
Chen, Z. et al. Recent progress in treatment of hepatocellular carcinoma. Am. J. Cancer Res. 10, 2993–3036 (2020).
pubmed: 33042631
pmcid: 7539784
Reig, M. et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J. Hepatol. 76, 681–693 (2022).
pubmed: 34801630
doi: 10.1016/j.jhep.2021.11.018
Llovet, J. M. et al. Immunotherapies for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 19, 151–172 (2022).
pubmed: 34764464
doi: 10.1038/s41571-021-00573-2
Sangro, B., Sarobe, P., Hervás-Stubbs, S. & Melero, I. Advances in immunotherapy for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 18, 525–543 (2021).
pubmed: 33850328
pmcid: 8042636
doi: 10.1038/s41575-021-00438-0
Zhang, R. et al. Adoptive cell transfer therapy for hepatocellular carcinoma. Front. Med. 13, 3–11 (2019).
pubmed: 30659408
doi: 10.1007/s11684-019-0684-x
Rochigneux, P. et al. Adoptive cell therapy in hepatocellular carcinoma: biological rationale and first results in early phase clinical trials. Cancers 13, 271 (2021).
pubmed: 33450845
pmcid: 7828372
doi: 10.3390/cancers13020271
Hou, A. J., Chen, L. C. & Chen, Y. Y. Navigating CAR-T cells through the solid-tumour microenvironment. Nat. Rev. Drug Discov. 20, 531–550 (2021).
pubmed: 33972771
doi: 10.1038/s41573-021-00189-2
Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).
pubmed: 33824268
pmcid: 8024391
doi: 10.1038/s41408-021-00459-7
Ghorashian, S. et al. Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR. Nat. Med. 25, 1408–1414 (2019).
pubmed: 31477906
doi: 10.1038/s41591-019-0549-5
Jafarzadeh, L. et al. Prolonged persistence of chimeric antigen receptor (CAR) T cell in adoptive cancer immunotherapy: challenges and ways forward. Front. Immunol. 11, 702 (2020).
pubmed: 32391013
pmcid: 7188834
doi: 10.3389/fimmu.2020.00702
Leonard, W. J., Lin, J. X. & O’Shea, J. J. The γ(c) family of cytokines: basic biology to therapeutic ramifications. Immunity 50, 832–850 (2019).
pubmed: 30995502
doi: 10.1016/j.immuni.2019.03.028
Dwyer, C. J. et al. Fueling cancer immunotherapy with common gamma chain cytokines. Front. Immunol. 10, 263 (2019).
pubmed: 30842774
pmcid: 6391336
doi: 10.3389/fimmu.2019.00263
Gargett, T. & Brown, M. P. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2. Cytotherapy 17, 487–495 (2015).
pubmed: 25573334
doi: 10.1016/j.jcyt.2014.12.002
Markley, J. C. & Sadelain, M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood 115, 3508–3519 (2010).
pubmed: 20190192
pmcid: 2867264
doi: 10.1182/blood-2009-09-241398
Cieri, N. et al. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood 121, 573–584 (2013).
pubmed: 23160470
doi: 10.1182/blood-2012-05-431718
Tian, Y. & Zajac, A. J. IL-21 and T cell differentiation: consider the context. Trends Immunol. 37, 557–568 (2016).
pubmed: 27389961
pmcid: 4969098
doi: 10.1016/j.it.2016.06.001
Hinrichs, C. S. et al. IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood 111, 5326–5333 (2008).
pubmed: 18276844
pmcid: 2396726
doi: 10.1182/blood-2007-09-113050
Chen, Y. et al. Adoptive transfer of interleukin-21-stimulated human CD8+ T memory stem cells efficiently inhibits tumor growth. J. Immunother. 41, 274–283 (2018).
pubmed: 29864078
pmcid: 6012057
doi: 10.1097/CJI.0000000000000229
Singh, H. et al. Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer Res. 71, 3516–3527 (2011).
pubmed: 21558388
pmcid: 3096697
doi: 10.1158/0008-5472.CAN-10-3843
Batra, S. A. et al. Glypican-3-specific CAR T cells coexpressing IL15 and IL21 Have superior expansion and antitumor activity against hepatocellular carcinoma. Cancer Immunol. Res. 8, 309–320 (2020).
pubmed: 31953246
pmcid: 10765595
doi: 10.1158/2326-6066.CIR-19-0293
Topchyan, P. et al. Harnessing the IL-21-BATF pathway in the CD8(+) T cell anti-tumor response. Cancers 13, 1263 (2021).
pubmed: 33809259
pmcid: 7998696
doi: 10.3390/cancers13061263
Cui, C. et al. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell 184, 6101–6118.e6113 (2021).
pubmed: 34852236
pmcid: 8671355
doi: 10.1016/j.cell.2021.11.007
Spolski, R. & Leonard, W. J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26, 57–79 (2008).
pubmed: 17953510
doi: 10.1146/annurev.immunol.26.021607.090316
Petrella, T. M. et al. Interleukin-21 has activity in patients with metastatic melanoma: a phase II study. J. Clin. Oncol. 30, 3396–3401 (2012).
pubmed: 22915661
doi: 10.1200/JCO.2011.40.0655
Shen, S. et al. Engineered IL-21 cytokine muteins fused to anti-PD-1 antibodies can improve CD8+ T cell function and anti-tumor immunity. Front. Immunol. 11, 832 (2020).
pubmed: 32457754
pmcid: 7225340
doi: 10.3389/fimmu.2020.00832
Daenthanasanmak, A. et al. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J. Clin. Investig. 128, 2787–2801 (2018).
pubmed: 29781812
pmcid: 6025986
doi: 10.1172/JCI95407
Kilian, M. et al. MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors. Cancer Cell 41, 235–251.e239 (2023).
pubmed: 36638785
doi: 10.1016/j.ccell.2022.12.007
Ngai, H. et al. LEF1 drives a central memory program and supports antitumor activity of natural killer T cells. Cancer Immunol. Res. 11, 171–183 (2023).
pubmed: 36484736
pmcid: 9898189
doi: 10.1158/2326-6066.CIR-22-0333
Okamura, R. M. et al. Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. Immunity 8, 11–20 (1998).
pubmed: 9462507
doi: 10.1016/S1074-7613(00)80454-9
Shi, D. et al. Chimeric antigen receptor-glypican-3 T-cell therapy for advanced hepatocellular carcinoma: results of phase I trials. Clin. Cancer Res. 26, 3979–3989 (2020).
pubmed: 32371538
doi: 10.1158/1078-0432.CCR-19-3259
Dai, H. et al. Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial. Oncoimmunology 9, 1846926 (2020).
pubmed: 33312759
pmcid: 7714531
doi: 10.1080/2162402X.2020.1846926
Zhou, X. & Xue, H. H. Cutting edge: generation of memory precursors and functional memory CD8+ T cells depends on T cell factor-1 and lymphoid enhancer-binding factor-1. J. Immunol. 189, 2722–2726 (2012).
pubmed: 22875805
doi: 10.4049/jimmunol.1201150
Cheng, G. et al. IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J. Immunol. 189, 1780–1791 (2012).
pubmed: 22786769
doi: 10.4049/jimmunol.1103768
Santegoets, S. J. et al. IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells. J. Transl. Med. 11, 37 (2013).
pubmed: 23402380
pmcid: 3626797
doi: 10.1186/1479-5876-11-37
Sutherland, A. P. et al. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet. J. Immunol. 190, 3977–3984 (2013).
pubmed: 23479229
doi: 10.4049/jimmunol.1201730
Shochat, C. et al. Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias. J. Exp. Med. 208, 901–908 (2011).
pubmed: 21536738
pmcid: 3092356
doi: 10.1084/jem.20110580
Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157–163 (2012).
pubmed: 22237106
pmcid: 3267575
doi: 10.1038/nature10725
Sun, Q. et al. STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection. J. Exp. Med. 220, e20220686 (2023).
pubmed: 36688918
pmcid: 9884582
doi: 10.1084/jem.20220686
Shum, T. et al. Constitutive signaling from an engineered IL7 receptor promotes durable tumor elimination by tumor-redirected T cells. Cancer Discov. 7, 1238–1247 (2017).
pubmed: 28830878
pmcid: 5669830
doi: 10.1158/2159-8290.CD-17-0538
Ding, Z. C. et al. Persistent STAT5 activation reprograms the epigenetic landscape in CD4(+) T cells to drive polyfunctionality and antitumor immunity. Sci. Immunol. 5, eaba5962 (2020).
pubmed: 33127608
pmcid: 8265158
doi: 10.1126/sciimmunol.aba5962
Zhu, W. et al. Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy. Hepatology 68, 574–589 (2018).
pubmed: 29443377
doi: 10.1002/hep.29844
Luo, X. et al. Selection of a clinical lead TCR targeting alpha-fetoprotein-positive liver cancer based on a balance of risk and benefit. Front. Immunol. 11, 623 (2020).
pubmed: 32425926
pmcid: 7203609
doi: 10.3389/fimmu.2020.00623
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).
pubmed: 30423086
pmcid: 6129281
doi: 10.1093/bioinformatics/bty560
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
pubmed: 22388286
pmcid: 3322381
doi: 10.1038/nmeth.1923
Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357–360 (2015).
pubmed: 25751142
pmcid: 4655817
doi: 10.1038/nmeth.3317
Pertea, M. et al. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat. Protoc. 11, 1650–1667 (2016).
pubmed: 27560171
pmcid: 5032908
doi: 10.1038/nprot.2016.095
Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290–295 (2015).
pubmed: 25690850
pmcid: 4643835
doi: 10.1038/nbt.3122
Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 12, 323 (2011).
doi: 10.1186/1471-2105-12-323
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e3529 (2021).
pubmed: 34062119
pmcid: 8238499
doi: 10.1016/j.cell.2021.04.048
Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).
pubmed: 31870423
pmcid: 6927181
doi: 10.1186/s13059-019-1874-1
Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829–845.e820 (2019).
pubmed: 31675496
doi: 10.1016/j.cell.2019.10.003
Qiu, X. et al. Single-cell mRNA quantification and differential analysis with Census. Nat. Methods 14, 309–315 (2017).
pubmed: 28114287
pmcid: 5330805
doi: 10.1038/nmeth.4150
Miao, Z., Deng, K., Wang, X. & Zhang, X. DEsingle for detecting three types of differential expression in single-cell RNA-seq data. Bioinformatics 34, 3223–3224 (2018).
pubmed: 29688277
doi: 10.1093/bioinformatics/bty332
Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics 16, 284–287 (2012).
pubmed: 22455463
pmcid: 3339379
doi: 10.1089/omi.2011.0118
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
pubmed: 34557778
pmcid: 8454663
Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083–1086 (2017).
pubmed: 28991892
pmcid: 5937676
doi: 10.1038/nmeth.4463
Huynh-Thu, V. A., Irrthum, A., Wehenkel, L. & Geurts, P. Inferring regulatory networks from expression data using tree-based methods. PLoS ONE 5, e12776 (2010).
pubmed: 20927193
pmcid: 2946910
doi: 10.1371/journal.pone.0012776
Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genomics Proteomics Bioinforma. 19, 578–583 (2021).
doi: 10.1016/j.gpb.2021.08.001
CNCB-NGDC Members and Partners. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res. 50, D27–D38 (2022).